Search research articles
Contact Us
Filters
Showing results (111-120 of 248) with videos related to
Page
of 25
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 1, 1994
Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine
B J Gertz, P Shao, D A Hanson, et al.
Journal of Neural Transmission. Supplementum
|
December 16, 1998
The prognosis of mild cognitive impairment in the elderly
H Wolf, M Grunwald, G M Ecke, et al.
British Journal of Clinical Pharmacology
|
October 6, 1999
Substance P-induced vasodilatation is mediated by the neurokinin type 1 receptor but does not contribute to basal vascular tone in man
D E Newby, D G Sciberras, C J Ferro, et al.
Epilepsia
|
May 21, 2009
Kv4.2 knockout mice demonstrate increased susceptibility to convulsant stimulation
L Forbes S Barnwell, Joaquin N Lugo, Wai L Lee, et al.
Spinal Cord
|
July 18, 2012
Brain EEG activity correlates of chronic pain in persons with spinal cord injury: clinical implications
M P Jensen, L H Sherlin, K J Gertz, et al.
European Journal of Clinical Pharmacology
|
July 6, 2000
Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans
M Depré, E Ehrich, A Van Hecken, et al.
JAMA
|
February 7, 1986
A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy
C M Mendel, R F Klein, D A Chappell, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1993
The gastrin-receptor antagonist L-365,260 inhibits stimulated acid secretion in humans
M G Murphy, B Sytnik, T O Kovacs, et al.
Deutsche Medizinische Wochenschrift (1946)
|
January 15, 2009
[MCI-plus: mild cognitive impairment with rapid progression. Part II: Biomarkers and research methods]
H Förstl, K Werheid, K Ulm, et al.
Deutsche Medizinische Wochenschrift (1946)
|
December 19, 2008
[MCI-plus: mild cognitive impairment with rapid progression. Part I: prevention and therapy]
H Förstl, H Bickel, L Frölich, et al.
Page
of 25
Search research articles
Search
Showing results (111-120 of 248) with videos related to
Sort By:
Page
of 25
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 1, 1994
Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine
B J Gertz, P Shao, D A Hanson, et al.
Journal of Neural Transmission. Supplementum
|
December 16, 1998
The prognosis of mild cognitive impairment in the elderly
H Wolf, M Grunwald, G M Ecke, et al.
British Journal of Clinical Pharmacology
|
October 6, 1999
Substance P-induced vasodilatation is mediated by the neurokinin type 1 receptor but does not contribute to basal vascular tone in man
D E Newby, D G Sciberras, C J Ferro, et al.
Epilepsia
|
May 21, 2009
Kv4.2 knockout mice demonstrate increased susceptibility to convulsant stimulation
L Forbes S Barnwell, Joaquin N Lugo, Wai L Lee, et al.
Spinal Cord
|
July 18, 2012
Brain EEG activity correlates of chronic pain in persons with spinal cord injury: clinical implications
M P Jensen, L H Sherlin, K J Gertz, et al.
European Journal of Clinical Pharmacology
|
July 6, 2000
Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans
M Depré, E Ehrich, A Van Hecken, et al.
JAMA
|
February 7, 1986
A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy
C M Mendel, R F Klein, D A Chappell, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1993
The gastrin-receptor antagonist L-365,260 inhibits stimulated acid secretion in humans
M G Murphy, B Sytnik, T O Kovacs, et al.
Deutsche Medizinische Wochenschrift (1946)
|
January 15, 2009
[MCI-plus: mild cognitive impairment with rapid progression. Part II: Biomarkers and research methods]
H Förstl, K Werheid, K Ulm, et al.
Deutsche Medizinische Wochenschrift (1946)
|
December 19, 2008
[MCI-plus: mild cognitive impairment with rapid progression. Part I: prevention and therapy]
H Förstl, H Bickel, L Frölich, et al.
Page
of 25